Europe — EMA
Dabigatran Etexilate Polpharma (Dabigatran Etexilate Mesilate)
Dabigatran Etexilate Polpharma is an oral medication used to prevent blood clots. It is commonly prescribed for conditions like atrial fibrillation and post-sur
Request sourcing
What is Dabigatran Etexilate Mesilate?
Dabigatran Etexilate Polpharma is an oral medication used to prevent blood clots. It is commonly prescribed for conditions like atrial fibrillation and post-surgery recovery. Learn more about its uses and effects.
What is Dabigatran Etexilate Mesilate used for?
Dabigatran Etexilate Polpharma is primarily used to reduce the risk of blood clots forming in the body. It is often prescribed for individuals with atrial fibrillation, a condition that can lead to irregular heartbeats and increase the risk of stroke. Additionally, it may be used post-surgery to prevent clots in people who are at higher risk. The medication works by inhibiting the formation of clots, thereby promoting better blood flow and reducing the likelihood of serious cardiovascular events.
What are the side effects of Dabigatran Etexilate Mesilate?
Common effects of Dabigatran Etexilate Polpharma may include mild bleeding, such as nosebleeds or bruising. Some users might experience stomach discomfort or heartburn. It is important to monitor for any signs of unusual bleeding, as this could indicate a need for medical attention. Always consult a healthcare provider if you experience severe or persistent side effects.
What precautions apply to Dabigatran Etexilate Mesilate?
Dabigatran Etexilate Polpharma should be handled with care, especially if you have a history of bleeding disorders or kidney problems. It is crucial to follow the prescribed dosage and not to stop taking the medication without consulting a healthcare provider. Store the medication in a cool, dry place away from direct sunlight and keep it out of reach of children.
What does Dabigatran Etexilate Mesilate interact with?
Dabigatran Etexilate Polpharma may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always consult a healthcare provider before starting or stopping any new medications while on Dabigatran Etexilate Polpharma.



